Equillium (EQ) Accumulated Depreciation (2017 - 2025)
Equillium (EQ) posted quarterly Accumulated Depreciation of $562000.0 for Q4 2025, up 12.63% year-over-year from $499000.0 in Q4 2024, and up 12.63% quarter-over-quarter from $499000.0 in Q4 2024.
Analysis
Equillium (EQ) Accumulated Depreciation (2017 - 2025) Analysis & Trends
Equillium (EQ) has reported Accumulated Depreciation for 9 consecutive years, with $562000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Accumulated Depreciation rose 12.63% year-over-year to $562000.0; the TTM figure through Dec 2025 stood at $562000.0 (up 12.63% YoY), while the FY2025 annual figure was $562000.0, up 12.63% from the prior year.
- Accumulated Depreciation climbed to $562000.0 in Q4 2025 per EQ's latest filing, from $499000.0 in the prior quarter.
- Across five years, Accumulated Depreciation topped out at $562000.0 in Q4 2025 and bottomed at $147000.0 in Q4 2021.
- Historically, Accumulated Depreciation has averaged $364200.0 across 5 years, with a median of $364000.0 in 2023.
- Annual changes were most pronounced in 2021 — Accumulated Depreciation jumped 98.65% — and 2025, when it increased 12.63%.
- Equillium's Accumulated Depreciation stood at $147000.0 in 2021, then surged by 69.39% to $249000.0 in 2022, then soared by 46.18% to $364000.0 in 2023, then surged by 37.09% to $499000.0 in 2024, then advanced by 12.63% to $562000.0 in 2025.
- Business Quant data shows EQ's Accumulated Depreciation at $562000.0 in Q4 2025, $499000.0 in Q4 2024, and $364000.0 in Q4 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Equillium | 249.33 Mn | 249.33 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 562,000.00 |
| Dec 31, 2024 | 499,000.00 |
| Dec 31, 2023 | 364,000.00 |
| Dec 31, 2022 | 249,000.00 |
| Dec 31, 2021 | 147,000.00 |
| Dec 31, 2020 | 74,000.00 |
| Dec 31, 2019 | 29,000.00 |
| Dec 31, 2018 | 6,000.00 |
| Dec 31, 2017 | 122.00 |